The Prevalence of Distal and Proximal Gastroesophageal Reflux in Patients Awaiting Lung Transplantation

Department of Surgery, University of California San Francisco, San Francisco, CA 94143-0790, USA.
Annals of Surgery (Impact Factor: 8.33). 11/2006; 244(4):491-7. DOI: 10.1097/01.sla.0000237757.49687.03
Source: PubMed


To determine the prevalence and proximal extent of gastroesophageal reflux (GERD) in patients awaiting lung transplantation.
GERD has been postulated to contribute to accelerated graft failure in patients who have had lung transplantations. However, the prevalence of reflux symptoms, esophageal motility abnormalities, and proximal esophageal reflux among patients with end-stage lung disease awaiting lung transplantation are unknown.
A total of 109 patients with end-stage lung disease awaiting lung transplantation underwent symptomatic assessment, esophageal manometry, and esophageal pH monitoring (using a probe with 2 sensors located 5 and 20 cm above the lower esophageal sphincter).
Reflux symptoms were not predictive of the presence of reflux (sensitivity, 67%; specificity, 26%). Esophageal manometry showed a high prevalence of a hypotensive lower esophageal sphincter (55%) and impaired esophageal peristalsis (47%) among patients with reflux. Distal reflux was present in 68% of patients and proximal reflux was present in 37% of patients.
These data show that in patients with end-stage lung disease: 1) symptoms were insensitive and nonspecific for diagnosing reflux; 2) esophageal motility was frequently abnormal; 3) 68% of patients had GERD; 4) in 50% of the patients with GERD, acid refluxed into the proximal esophagus. We conclude that patients with end-stage lung disease should be screened with pH monitoring for GERD.

Download full-text


Available from: Charles W Hoopes, Aug 14, 2014
16 Reads
  • Source
    • "In four patients with end-stage bronchiectasis, who completed dual-channel oesophageal pH monitoring, the prevalence of distal reflux of 75% and proximal reflux of 50% suggests that patients with more severe bronchiectasis may be more likely to have GOR [54]. However, the relationship of reflux to clinical presentation or its association with lung disease severity was not evaluated [54]. Similar results were found in a study of seven patients with advanced bronchiectasis awaiting lung transplantation, with 33% experiencing an increased number of distal reflux episodes, specifically in the supine position [55]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The clinical presentation of noncystic fibrosis bronchiectasis may be complicated by concomitant conditions, including gastro-oesophageal reflux (GOR). Increased acidic GOR is principally caused by gastro-oesophageal junction incompetence and may arise from lower oesophageal sphincter hypotension, including transient relaxations, hiatus hernia, and oesophageal dysmotility. Specific pathophysiological features which are characteristic of respiratory diseases including coughing may further increase the risk of GOR in bronchiectasis. Reflux may impact on lung disease severity by two mechanisms, reflex bronchoconstriction and pulmonary microaspiration. Symptomatic and clinically silent reflux has been detected in bronchiectasis, with the prevalence of 26 to 75%. The cause and effect relationship has not been established, but preliminary reports suggest that GOR may influence the severity of bronchiectasis. Further studies examining the implications of GOR in this condition, including its effect across the disease spectrum using a combination of diagnostic tools, will clarify the clinical significance of this comorbidity.
    Pulmonary Medicine 11/2011; 2011:395020. DOI:10.1155/2011/395020
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The association between gastroesophageal reflux disease and idiopathic pulmonary fibrosis has not been fully characterized. The aims of this study were to determine in patients with idiopathic pulmonary fibrosis (1) the prevalence of reflux symptoms, (2) the esophageal manometric profile, and (3) the prevalence of proximal and distal esophageal reflux. Between May 1999 and March 2006, 30 patients with idiopathic pulmonary fibrosis were referred to the Swallowing Center at the University of California San Francisco. Each patient underwent a structured symptom assessment, esophageal manometry, and 24-hour dual sensor ambulatory pH monitoring. Twenty (67%) patients had abnormal esophageal reflux. Typical reflux symptoms, although more common in those with reflux, were not reliable as a screening test (sensitivity 65%, specificity 71%). Sixty-five percent of patients with abnormal reflux had a hypotensive lower esophageal sphincter. Abnormal esophageal peristalsis was more common among those with reflux (50% vs 10%; P = .03). In 9 (30%) patients, acid refluxed into the proximal esophagus for over 1% of the study time. A majority of patients with idiopathic pulmonary fibrosis have pathologic reflux. Symptoms do not distinguish between those with and without reflux. In these patients, reflux is associated with a hypotensive lower esophageal sphincter and abnormal esophageal peristalsis, and often extends into the proximal esophagus.
    The Journal of thoracic and cardiovascular surgery 05/2007; 133(4):1078-84. DOI:10.1016/j.jtcvs.2006.09.085 · 4.17 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: More than 50 years have passed since Rudolf Nissen astutely noticed the effects of his gastroplication on prevention of gastroesophageal reflux. Much progress has been made in understanding the pathophysiology, diagnosis, and treatment of gastroesophageal reflux disease (GERD). Antireflux surgery is an important component of the treatment options, applicable in 10% to 15% of patients with symptoms of GERD. Its application, however, is more complex than meets the eye. Considerable judgment in patient selection, careful preoperative evaluation, appropriate selection of the ideal procedure, and proper surgical technique are required to achieve a high degree of success. The data reviewed here show that when these factors are present, outcomes are reproducible and excellent. Recent clinical research focusing on the physiology of fundoplication, symptom control, patient satisfaction, and the postoperative quality of life have taught us much, as has the careful analysis of complications and surgical failures. We anticipate that advances in our understanding of GERD will continue to enable clinicians to treat this disease with increasing effectiveness and efficiency.
    Current GERD Reports 11/2007; 1(4):233-240. DOI:10.1007/s12171-007-0023-z
Show more